TITLE

Differentiation of Osteoblasts and Osteocytes from Mesenchymal Stem Cells

AUTHOR(S)
Heino, Terhi J.; Hentunen, Teuvo A.
PUB. DATE
May 2008
SOURCE
Current Stem Cell Research & Therapy;May2008, Vol. 3 Issue 2, p131
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mesenchymal stem cells (MSCs) are multipotent cells that arise from the mesenchyme during development. They reside in the bone marrow close to hematopoietic stem cell niches allowing them to maintain bone marrow homeostasis and to regulate the maturation of both hematopoietic and non-hematopoietic cells. MSCs possess an extensive potential to proliferate and differentiate e.g. into osteoblasts, osteocytes, adipocytes and chondrocytes. Nevertheless, there still are some open questions about the complex process of MSC differentiation involving different transcription factors and signaling pathways, which will be discussed in this review. We also shortly introduce the characteristics and function of bone-forming osteoblasts and their role in angiogenesis. MSCs are of interest in clinical applications, since they can be easily isolated from bone marrow aspirates and expanded in vitro. When the source of osteoprogenitors is compromised, cell-based therapies could provide a novel way to repair bone defects. Indeed, there is an increasing interest in the use of MSCs and more differentiated cells in clinical applications for bone repair, which will be introduced in this review. A major section of the review is dedicated to the functions of osteocytes in the regulation of bone remodeling. Finally, we present an original hypothesis about the possible role of osteocytes in future bone tissue engineering.
ACCESSION #
62090468

 

Related Articles

  • Bone Regeneration and Repair. Panetta, Nicholas J.; Gupta, Deepak M.; Longaker, Michael T. // Current Stem Cell Research & Therapy;Jun2010, Vol. 5 Issue 2, p122 

    In the face of mounting clinical demand, and armed with reconstructive techniques that are technically challenging and frequently result in suboptimal patient outcomes, increasing focus is being placed on tissue engineering and regenerative medicine as a potential source of novel skeletal...

  • Current view of mesenchymal stem cells biology (brief review). Maslova, O. O. // Biopolymers & Cell;2012, Vol. 28 Issue 3, p190 

    Although mesenchymal stem cells (MSC) are in a focus of attention, some aspects of their biology are still unclear. This paper is a review of current research on MSC biology. The use of MSC in regenerative medicine is also briefly discussed.

  • Umbilical Cord Lining Membrane and Wharton's Jelly-Derived Mesenchymal Stem Cells: the Similarities and Differences. Jeschke, Marc G.; Gauglitz, Gerd G.; Phan, Thang T.; Herndon, David N.; Kita, Katsuhiro // Open Tissue Engineering & Regenerative Medicine Journal;2011, Vol. 4, p21 

    The umbilical cord tissue has gained attention in recent years as a source of multipotent cells. Due to its widespread availability, the umbilical cord may be an excellent alternative source of cells for regenerative medicine. Anatomically, umbilical cord tissue is constituted of several...

  • Safety and Complications Reporting on the Re-implantation of Culture-Expanded Mesenchymal Stem Cells using Autologous Platelet Lysate Technique. Centeno, Christopher J.; Schultz, John R.; Cheever, Michelle; Robinson, Brent; Freeman, Michael; Marasco, Wayne // Current Stem Cell Research & Therapy;Mar2010, Vol. 5 Issue 1, p81 

    Mesenchymal stem cells (MSCs) hold great promise as therapeutic agents in regenerative medicine. Numerous animal studies have documented the multipotency of MSCs, showing their capabilities for differentiating into orthopedic tissues such as muscle, bone, cartilage, and tendon. However, the...

  • First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells. Wataru Katagiri; Masashi Osugi; Takamasa Kawai; Hideharu Hibi // Head & Face Medicine;1/15/2016, Vol. 12, p1 

    Background: Secreted growth factors and cytokines in the conditioned medium from bone marrow-derived mesenchymal stem cells (MSC-CM) have several effects on cell behavior. Our previous studies revealed that MSC-CM enhances bone regeneration by increasing cell mobilization, angiogenesis, and...

  • CD105 (Endoglin)-Negative Murine Mesenchymal Stromal Cells Define a New Multipotent Subpopulation with Distinct Differentiation and Immunomodulatory Capacities. Anderson, Per; Carrillo-Gálvez, Ana Belén; García-Pérez, Angélica; Cobo, Marién; Martín, Francisco // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo- and xenogeneic settings. However, MSC preparations are heterogeneous which...

  • Differential effects of platelet rich plasma and washed platelets on the proliferation of mouse MSC cells. Jianmin Duan; Wei Kuang; Jiali Tan; Hongtao Li; Yi Zhang; Kikuchi Hirotaka; Katayama Tadashi // Molecular Biology Reports;Apr2011, Vol. 38 Issue 4, p2485 

    Multipotent mesenchymal stem cell (MSC) therapies are being tested clinically for a variety of disorders. However, despite the remarkable clinical advancements in this field, most applications still use traditional culture media containing fetal bovine serum. Platelet-rich plasma (PRP) appears...

  • Integration of Rabbit Adipose Derived Mesenchymal Stem Cells to Hydroxyapatite Burr Hole Button Device for Bone Interface Regeneration. Gayathri, Viswanathan; Harikrishnan, Varma; Mohanan, Parayanthala Valappil // International Journal of Biomaterials;1/5/2016, p1 

    Adipose Derived Mesenchymal Stem Cells, multipotent stem cells isolated from adipose tissue, present close resemblance to the natural in vivo milieu and microenvironment of bone tissue and hence widely used for in bone tissue engineering applications. The present study evaluates the...

  • Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem Cells. Jones, Gemma N.; Moschidou, Dafni; Puga-Iglesias, Tamara-Isabel; Kuleszewicz, Katarzyna; Vanleene, Maximilien; Shefelbine, Sandra J.; Bou-Gharios, George; Fisk, Nicholas M.; David, Anna L.; De Coppi, Paolo; Guillot, Pascale V.; Xing-Ming Shi // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Human mesenchymal stromal/stem cells (MSC) isolated from fetal tissues hold promise for use in tissue engineering applications and cell-based therapies, but their collection is restricted ethically and technically. In contrast, the placenta is a potential source of readily-obtainable stem cells...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics